Your browser doesn't support javascript.
loading
Universal risk assessment upon hospital admission for screening of carriage with multidrug-resistant micro-organisms in a Dutch tertiary care centre.
van Hout, D; Bruijning-Verhagen, P C J; Blok, H E M; Troelstra, A; Bonten, M J M.
Affiliation
  • van Hout D; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. Electronic address: D.vanHout-3@umcutrecht.nl.
  • Bruijning-Verhagen PCJ; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
  • Blok HEM; Department of Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Troelstra A; Department of Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Bonten MJM; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands; Department of Medical Microbiology, Univer
J Hosp Infect ; 109: 32-39, 2021 Mar.
Article de En | MEDLINE | ID: mdl-33347938
ABSTRACT

BACKGROUND:

In Dutch hospitals a six-point questionnaire is currently mandatory for risk assessment to identify carriers of multidrug-resistant organisms (MDROs) at the time of hospitalization. Presence of one or more risk factors is followed by pre-emptive isolation and microbiological culturing.

AIM:

To evaluate the yield of the universal risk assessment in identifying MDRO carriers upon hospitalization.

METHODS:

A cross-sectional study was performed using routine healthcare data in a Dutch tertiary hospital between January 1st, 2015 and August 1st, 2019. MDRO risk assessment upon hospitalization included assessment of known MDRO carriage, previous hospitalization in another Dutch hospital during an outbreak or a foreign hospital, living in an asylum centre, exposure to livestock farming, and household membership of a meticillin-resistant Staphylococcus aureus carrier.

FINDINGS:

In total, 144,051 admissions of 84,485 unique patients were included; 4480 (3.1%) admissions had a positive MDRO risk assessment. In 1516 (34%) admissions microbiological screening was performed, of which 341 (23%) yielded MDRO. Eighty-one patients were categorized as new MDRO carriers, as identified through MDRO risk assessment, reflecting 0.06% (95% confidence interval 0.04-0.07) of all admissions and 1.8% (1.4-2.2) of those with positive risk assessment. As a result, the number of 'MDRO risk assessments needed to perform' and individual 'MDRO questions needed to ask' to detect one new MDRO carrier upon hospitalization were 1778 and 10,420, respectively.

CONCLUSION:

The yield of the current strategy of MDRO risk assessment upon hospitalization is limited and it needs thorough reconsideration.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: État de porteur sain / Dépistage de masse / Appréciation des risques / Multirésistance bactérienne aux médicaments / Staphylococcus aureus résistant à la méticilline Type d'étude: Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limites: Humans Pays/Région comme sujet: Europa Langue: En Journal: J Hosp Infect Année: 2021 Type de document: Article

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: État de porteur sain / Dépistage de masse / Appréciation des risques / Multirésistance bactérienne aux médicaments / Staphylococcus aureus résistant à la méticilline Type d'étude: Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limites: Humans Pays/Région comme sujet: Europa Langue: En Journal: J Hosp Infect Année: 2021 Type de document: Article